The effects of anabolic androgenic steroids on serum ubiquinone and dolichol levels among steroid abusers

Metabolism: Clinical and Experimental

Volumn 45, Issue 7, 1996, Pages 844-847

  Karila, Tuomo ^a   Laaksonen, Reijo ^b   Jokelainen, Kalle ^b   Himberg, Jaakko Juhan ^b   Seppälä, Timo ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANDROGEN; DOLICHOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STEROID; TRIACYLGLYCEROL; UBIQUINONE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; DRUG ABUSE; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SUBSTANCE ABUSE;

EID: 0029952054     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90157-2     Document Type: Article

References (28)

1. Terney R, McLain L: The use of anabolic steroids in high school students. Am J Dis Child 144:99-103, 1990
2. Windsor R, Dumitru D: Prevalence of anabolic steroid use by male and female adolescents. Med Sci Sports Exerc 21:494-497, 1989
3. Buckley WE, Yesalis CE, Friedl KE, et al: Estimated prevalence of anabolic steroid use among male high school seniors. JAMA 260:3441-3445, 1988
4. Friedl K: Reappraisal of the health risks associated with the use of high doses of oral and injectable anabolic steroids, in Anabolic Steroid Abuse, NIDA Research Monograph. Rockville, MD, National Institute on Drug Abuse, 1990
5. Wilson J: Androgen abuse by athletes. Endocr Rev 9:81-199, 1988
6. Gwynne J, Straus SJ: The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands. Endocr Rev 3:299-329, 1982
7. Glazer G: Atherogenic effects of anabolic steroids on serum lipid levels. A literature review. Arch Intern Med 151:1925-1933, 1991
8. Donike M, Geyer H, Gotzmann A, et al: 1988 Dope analysis, in Bellotti P, Benzi G, Ljungqist A (eds): Official Proceedings of the International Athletic Foundation World Symposium on Doping in Sport - 1987. London, UK, International Athletic Foundation, 1988, pp 53-80
9. 2+/dextran sulphate in its enzymatic measurement. Clin Chem 24:931-933, 1978
10. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
11. Laaksonen R, Riihimäki A, Laitila J, et al: Serum and muscle tissue ubiquinone levels in healthy subjects. J Clin Lab Med 25:517-521, 1995
12. Jokelainen K, Salmela K, Humaloja K, et al: Blood dolichol in lysosomal diseases. Biochem Cell Biol 70:481-485, 1992
13. Systat: Systat for Windows: Statistics, version 5. Evanston, IL, Systat, 1992
14. Webb O, Laskarzewski P, Glueck C: Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids. Metabolism 33:971-975, 1984
15. Olson RE, Rudney H: Biosynthesis of ubiquinone. Vitam Horm 40:1-43, 1983
16. Stocker R, Bowry VW, Frei B: Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci USA 88:1646-1650, 1991
17. Karlsson J, Diamant B, Folkers K: Skeletal muscle characteristics of significance for metabolism in health and disease. Adv Myochem 2:283-291, 1989
18. Karlsson J, Diamant B, Folkers K, et al: Plasma ubiquinone and cholesterol contents with and without ubiquinone treatment, in Lenaz G, Barnabe O, Rabbi A, et al (eds): Highlights in Ubiquinone Research. London, UK, Taylor & Francis, 1990, pp 296-302
19. Rip J, Rupar C, Ravi K, et al: Distribution, metabolism and function of dolichol and polyprenols. Prog Lipid Res 24:269-309, 1985
20. Marino M, Bruscalupi G, Manzi P, et al: Changes in plasma dolichol levels, transport, and hepatic delivery during rat liver regeneration. Metabolism 43:677-680, 1994
21. Lai C, Schutzbach J: Dolichol induces membrane leakage of liposomes composed of phosphatidylethanolamine and phosphatidylcholine. FEBS Lett 169:279-282, 1984
22. Valtersson C, van Duijn A, Verkleij T, et al: The influence of dolichol, dolichol esters, and dolichyl phosphate on phospholipid polymorphism and fluidity in model membranes. J Biol Chem 260:2742-2751, 1985
23. Yasugi E, Oshima M: Sequential microanalyses of free dolichol, dolichyl fatty acid ester and dolichyl phosphate levels in human serum. Biochim Biophys Acta 1211:107-113, 1994
24. Siperstain M: Role of cholesterogenesis and isoprenoid synthesis in DNA replication and cell growth. J Lipid Res 25:1462-1468, 1984
25. Santos E, Nebreda A: Structural and functional properties of ras proteins. Fed Am Soc Exp Biol J 3:2151-2163, 1989
26. Mendola C, Baker J: Lovastatin blocks N-ras oncogeneinduced neuronal differentiation. Cell Growth Diff 1:499-502, 1990
27. Craig J, Peters R, Edmondson H: Atlas of Tumor Pathology, Second Series, Fascicle 26: Tumor of the Liver and Intrahepatic Bile Ducts. Washington, DC, Armed Forces Institute of Pathology, 1989, pp 36-41
28. Anthony P: Hepatoma associated with androgenic steroids. Lancet 1:685-686, 1975